Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.

MLA

Daemen, Toos, et al. “Superior Therapeutic Efficacy of Alphavirus-Mediated Immunization against Human Papilloma Virus Type 16 Antigens in a Murine Tumour Model: Effects of the Route of Immunization.” Antiviral Therapy, vol. 9, no. 5, Oct. 2004, pp. 733–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15535411&authtype=sso&custid=ns315887.

APA

Daemen, T., Riezebos-Brilman, A., Regts, J., Dontje, B., van der Zee, A., & Wilschut, J. (2004). Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization. Antiviral Therapy, 9(5), 733–742.

Chicago

Daemen, Toos, Annelies Riezebos-Brilman, Joke Regts, Bert Dontje, Ate van der Zee, and Jan Wilschut. 2004. “Superior Therapeutic Efficacy of Alphavirus-Mediated Immunization against Human Papilloma Virus Type 16 Antigens in a Murine Tumour Model: Effects of the Route of Immunization.” Antiviral Therapy 9 (5): 733–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15535411&authtype=sso&custid=ns315887.